Advertisement

Cardiovascular Intervention and Therapeutics

, Volume 33, Issue 4, pp 391–392 | Cite as

Very late scaffold thrombosis one week after the discontinuation of dual antiplatelet therapy

  • Futoshi Yamanaka
  • Koki Shishido
  • Shigeru Saito
Images in Cardiovascular Intervention

Notes

Compliance with ethical standards

Conflict of interest

None.

Supplementary material

12928_2017_485_MOESM1_ESM.avi (86.9 mb)
Supplementary material 1 (AVI 89035 kb)

References

  1. 1.
    Onuma Y, Serruys PW, Muramatsu T, et al. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2014;7:1400–11.CrossRefGoogle Scholar
  2. 2.
    Kimura T, Kozuma K, Tanabe K, et al. A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36:3332–42.CrossRefGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2017

Authors and Affiliations

  • Futoshi Yamanaka
    • 1
  • Koki Shishido
    • 1
  • Shigeru Saito
    • 1
  1. 1.Department of Cardiology and Catheterization LaboratoryShonankamakura General HospitalKamakuraJapan

Personalised recommendations